The Glomerular Disease Registry and Biobank (GRIT) will facilitate the discovery of potential genetic markers and novel therapeutic options for patients with glomerular diseases
What is the issue for NSW?
Glomerular disease is associated with serious morbidity and mortality, accounting for 20% of all incident end stage kidney disease with few proven treatments.
What does the research aim to do and how?
This study will support the collection and storage of blood samples for patients with glomerular disease which can be used in research and clinical trials to address the challenges of treatments for patients with glomerular disease.